$6.675
-0.621 (-9.31%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EPRX Prediction & Forecast by Similar Chart Analysis
Alphio's EPRX stock price prediction model matches the current Eupraxia Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.77 (+1.48%). The 1-week path is $6.74 (+0.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Eupraxia Pharmaceuticals Inc Stock?
Eupraxia Pharmaceuticals Inc (EPRX) is a good buy right now due to its current price of $6.67, which is significantly below analyst price targets, with Oppenheimer setting a target of $17 and Stifel at $25. The recent positive Phase 1b/2a data for its lead therapy EP-104GI shows a 72% reduction in eosinophil count, indicating strong potential for future growth. However, the company reported a widening net loss of $12.7 million for Q1 2026, which is a risk to consider.
EPRX stock price ended at $6.68 on Friday, after losing -9.31%
Eupraxia Pharmaceuticals Inc (EPRX) last closed at $6.675, losing -9.31%. These facts feed the 1-day and 1-week EPRX price prediction above.
Forecast Drivers
Eupraxia Pharmaceuticals Inc (EPRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches EPRX, ranked by similarity.
Seasonality analysis for EPRX
Historically the probability of a positive August return for EPRX is 33.33%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EPRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $4.14 | $4.72 | $5.73 | -29.29% |
| Sep 2026 | $5.28 | $6.39 | $6.83 | -4.34% |
| Oct 2026 | $4.65 | $4.97 | $5.79 | -25.49% |
| Nov 2026 | $4.25 | $5.14 | $5.37 | -22.92% |
| Dec 2026 | $5.49 | $5.70 | $6.53 | -14.55% |
In 2026, Eupraxia Pharmaceuticals Inc (EPRX) is projected to range from $4.14 to $6.83.
Eupraxia Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Eupraxia Pharmaceuticals Inc is projected to average $4.72, with a low of $4.14 and high of $5.73.
In Sep 2026, Eupraxia Pharmaceuticals Inc is projected to average $6.39, with a low of $5.28 and high of $6.83.
In Oct 2026, Eupraxia Pharmaceuticals Inc is projected to average $4.97, with a low of $4.65 and high of $5.79.
In Nov 2026, Eupraxia Pharmaceuticals Inc is projected to average $5.14, with a low of $4.25 and high of $5.37.
In Dec 2026, Eupraxia Pharmaceuticals Inc is projected to average $5.70, with a low of $5.49 and high of $6.53.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.